DECEMBER 17, 2023

Study Underscores Need to Evaluate for Liver Disease in Patients With C. diff

Patients with Clostridioides difficile infections who also have metabolic dysfunction–associated steatohepatitis are at increased risk for death and other severe complications, according to a retrospective study drawn from the National Inpatient Sample.

The investigators, from Rutgers-Robert Wood Johnson Medical School, in New Brunswick, N.J., noted that there is evidence that metabolic-dysfunction–associated steatotic liver disease (MASLD) or metabolic-dysfunction–associated